Auditor examines 340B drug discount program impact

The Illinois Legislature approved file HB4327 ("Auditor examines 340B drug discount program impact"), by a recorded vote of 161 to 8. Last action: August 7, 2026.

Illinois file HB4327, before the Illinois Legislature. Passed as of 2026-08-07.

What it does

Taxpayers get transparency on state health program costs The Auditor General will investigate how 340B covered entities (hospitals, nonprofits, clinics) use federal drug discounts and whether participation affects what Illinois pays for Medicaid and employee health insurance, with findings and recommendations due to lawmakers.

The bigger picture

May reveal savings or cost pressures in state budgets Audit findings could show whether 340B participation reduces state health program spending, increases it, or shifts costs between programs—potentially informing future policy on drug pricing, program eligibility, or reimbursement rates.

Official summary

Amends the Illinois State Auditing Act. Provides that, as soon as practical after the effective date of the amendatory Act, the Auditor General shall conduct a comprehensive investigation of how 340B covered entities within Illinois participate in the 340B Drug Discount Program. Provides that the investigation shall examine the impact of this participation by 340B covered entities on State health programs, such as Medicaid and the State Employees Group Insurance Program, and shall include the specified assessments. Requires the Auditor General to make recommendations to the General Assembly based on the findings from the investigation.

How they voted

Yes (161)

No (8)

Did not vote / other (6)

Read the official record for HB4327

See everything up for a vote · This week in Illinois · See what we have filed with the clerk